Загрузка...
Rationale for a Neisseria gonorrhoeae Susceptible Only Interpretive Breakpoint for Azithromycin
BACKGROUND: Azithromycin (AZI) is recommended with Ceftriaxone (CRO) for treatment of uncomplicated gonococcal urethritis and cervicitis in the United States (US) and an AZI susceptibility breakpoint is needed. Neither the FDA (Food and Drug Administration) nor the CLSI (Clinical and Laboratory Stan...
Сохранить в:
| Опубликовано в: : | Clin Infect Dis |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6785360/ https://ncbi.nlm.nih.gov/pubmed/30963175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz292 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|